- Medtronic is a leader in the medical device field with three strong groups: cardiac/vascular, restorative, and diabetes.
- Revenues rose 5% for the latest quarter.
- The company is standing by its earnings guidance and revenue outlook.
- Revenues are taking off for the Diabetes Group, with a 12% increase in sales.
- The stock has an extensive track record of dividend increases.